SAN DIEGO, CA | PEORIA, IL | MELBOURNE, FL – 9 Jan, 2017 – Optimal Research announced today the launch of recruitment efforts for a phase one zika vaccine study at three of their US based locations. This effort comes in response to the World Health Organization’s (WHO) declaration of an international public health emergency due to the rise in microcephaly and other neurological disorder cases related to the zika virus outbreak.
“Optimal Research is proud to be active in providing a potential solution for the health crisis. Together, with our partners and governmental agencies, we hope this study shows promise for an effective preventive vaccine.” – Dr. Stephan A Bart, Sr. CMO and President of Optimal Research
The zika vaccine research study aims to induce immunity and provide protection against the infection caused by the zika virus. The participating sites are seeking healthy volunteers ages 18-49 to participate in the study, with a special need for one third of participants having documentation of a prior yellow fever vaccine. These individuals may have been prior service military, doctors without borders, or travelers to endemic areas like South America or Africa.
Optimal Research, one of the first US based research site to begin work on the Ebola epidemic, has been selected to conduct inaugural research combatting this global health crisis. The company is best known for work in infectious disease, oncology, pediatric and vaccine research, with the initial participating US based sites for the zika vaccine study located in San Diego CA, Melbourne FL, and Peoria IL.
“Our volunteers never cease to amaze us in their willingness to participate in world health studies. This vaccine is especially important because of the ramifications to our most vulnerable population. We are honored to play our part.” – Michelle Peek, Center Manager Optimal Research, San Diego CA
To participate as a volunteer in this study, please visit: www.optimalsites.net/zika
Optimal Research provides clinical site solutions to pharmaceutical and biotech companies, medical device companies, and contract research organizations (CROs) seeking research sites to conduct clinical research studies in a high quality manner.
For more information, visit:
If you would like more information about this topic or how you can volunteer to help, please contact Hoefer, Holly at 240-238-4957 or email at firstname.lastname@example.org
Distributed by Press Release Jet
Company Name: Optimal Research
Contact Person: Holly Ford Hoefer
Country: United States